Oxford BioMedica Moving To LSE Following TroVax Trial Approval Jan. 10, 2001 By Nuala Moran No Comments
Oxxon Plans Moves Into Phase II Following £4.7M Private Funding Jan. 3, 2001 By Nuala Moran No Comments
Scotia Sells Assets, Buys Time While Awaiting Foscan Decision Jan. 3, 2001 By Nuala Moran No Comments
Oxxon Plans Moves Into Phase II Following £4.7M Private Funding Jan. 3, 2001 By Nuala Moran No Comments
Scotia Sells Assets, Buys Time While Awaiting Foscan Decision Jan. 3, 2001 By Nuala Moran No Comments
